nucleic acid detection
Depixus Seeks to Commercialize 'Magnetic Tweezers' for Drug Discovery, Liquid Biopsy Research
Premium
The firm is looking to collaborate with researchers to showcase its ability to repeatedly analyze DNA and RNA molecules with different assays.
Broad Institute, Collaborators Eye CRISPR Panel to Detect SARS-CoV-2 Variants, Respiratory Viruses
Premium
The group has developed a panel to detect SARS-CoV-2, other coronaviruses, and influenza A and B that also identified and differentiated six variant lineages.
Nucleic Acid Analysis Startup Depixus Raises €30.6M in Series A Financing
Lansdowne Partners and France's PSIM Fund led the financing round and were joined by Casdin Capital and existing investors, including Arix Bioscience.
WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance
The findings stem from a recent meeting of a WHO Guideline Development Group convened to address challenges with TB diagnosis and related drug-resistance.
Cardea Bio Raises $6.5M in Series A Extension
The company said it will use the financing to further develop its Transistor molecular detection platform and significantly expand mass manufacturing.